AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Chesapeake Utilities Corporation (CPK) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company demonstrates strong 11.8% EPS growth, the current 21.09 P/E ratio and heavy reliance on external financing to fund a 120.3% CapEx-to-OCF ratio warrant a cautious approach regarding future valuation upside.
Chesapeake Utilities Corporation (CPK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Chesapeake Utilities Corporation (CPK) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $2.47vs $2.38+3.8% | $353Mvs $340M+3.9% |
| Q1 2026 | Feb 25, 2026 | $1.94vs $1.94+0.0% | $259Mvs $209M+24.1% |
| Q4 2025 | Nov 6, 2025 | $0.82vs $0.90-8.9% | $180Mvs $235M-23.6% |
| Q3 2025 | Aug 7, 2025 | $1.04vs $1.00+4.0% | $193Mvs $182M+5.7% |
Recent stock market news and headlines for Chesapeake Utilities Corporation (CPK)
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Chesapeake Utilities (CPK) have what it takes?

Key metrics vs top competitors for Chesapeake Utilities Corporation (CPK)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $124.33 | $2.98B | 20.83 | 18.14% | 15.09% | 9.39% | 2.08% | |
| $81.04 | $4.79B | 18.54 | -4.5% | 14.12% | 10.44% | — | |
| $57.47 | $5.8B | 17.26 | 13.94% | 15.45% | 18.74% | — | |
| $23.72 | $246.86M | 18.39 | 12.63% | 13.01% | 11.87% | — | |
| $88.51 | $6.41B | 14.56 | -62.05% | 18.55% | 11.53% | — | |
| $77.84 | $4.89B | 17.81 | 16.5% | 11.77% | 8.2% | — |
Chesapeake Utilities Corporation (CPK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Chesapeake Utilities Corporation (CPK) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 8, 2026·SEC
May 6, 2026·SEC
Mar 24, 2026·SEC
Get notified when CPK posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Chesapeake Utilities Corporation (CPK) stock FAQ — growth, dividends, profitability & financials explained
Chesapeake Utilities Corporation (CPK) reported $984.5M in revenue for fiscal year 2025. This represents a 725% increase from $119.3M in 1996.
Chesapeake Utilities Corporation (CPK) grew revenue by 18.1% over the past year. This is strong growth.
Yes, Chesapeake Utilities Corporation (CPK) is profitable, generating $148.7M in net income for fiscal year 2025 (15.1% net margin).
Yes, Chesapeake Utilities Corporation (CPK) pays a dividend with a yield of 2.08%. This makes it attractive for income-focused investors.
Chesapeake Utilities Corporation (CPK) has a return on equity (ROE) of 9.4%. This is below average, suggesting room for improvement.
Chesapeake Utilities Corporation (CPK) had negative free cash flow of $297.5M in fiscal year 2025, likely due to heavy capital investments.
Chesapeake Utilities Corporation (CPK) has a dividend payout ratio of 43%. This suggests the dividend is well-covered and sustainable.